UPDATE 1-Roche to buy U.S. biotech firm InterMune for $8.3 bln By: Reuters: Company News August 24, 2014 at 13:06 PM EDT * Roche sees transaction neutral for core EPS in 2015 (Adds further comment from Roche, background) Read More >> Related Stocks: AbbVie Astrazeneca Plc ADR Pfizer Rogers Corp